Carriero MV - Search Results

1

Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating alpha(v)beta5 vitronectin receptor cell surface expression.

Silvestri I, Longanesi Cattani I, Franco P, Pirozzi G, Botti G, Stoppelli MP, Carriero MV. Silvestri I, et al. Among authors: carriero mv. Int J Cancer. 2002 Dec 20;102(6):562-71. doi: 10.1002/ijc.10744. Int J Cancer. 2002. PMID: 12447996

2

Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels.

Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, et al. Del Vecchio S, et al. Among authors: carriero mv. Cancer Res. 1993 Jul 1;53(13):3198-206. Cancer Res. 1993. PMID: 7686450

3

Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.

Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M. Carriero MV, et al. Cancer Res. 1994 Oct 15;54(20):5445-54. Cancer Res. 1994. PMID: 7923178

4

Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography.

Li PY, Del Vecchio S, Fonti R, Carriero MV, Potena MI, Botti G, Miotti S, Lastoria S, Menard S, Colnaghi MI, Salvatore M. Li PY, et al. Among authors: carriero mv. J Nucl Med. 1996 Apr;37(4):665-72. J Nucl Med. 1996. PMID: 8691264 Free article.

5

In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients.

Vecchio SD, Ciarmiello A, Potena MI, Carriero MV, Mainolfi C, Botti G, Thomas R, Cerra M, D'Aiuto G, Tsuruo T, Salvatore M. Vecchio SD, et al. Among authors: carriero mv. Eur J Nucl Med. 1997 Feb;24(2):150-9. doi: 10.1007/BF02439547. Eur J Nucl Med. 1997. PMID: 9021112

6

In vitro receptor imaging for characterization of human solid tumors.

Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, et al. Del Vecchio S, et al. Among authors: carriero mv. Nucl Med Biol. 1994 Jul;21(5):771-4. doi: 10.1016/0969-8051(94)90048-5. Nucl Med Biol. 1994. PMID: 9241653

7

Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.

Ciarmiello A, Del Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, Botti G, D'Aiuto G, Salvatore M. Ciarmiello A, et al. Among authors: carriero mv. J Clin Oncol. 1998 May;16(5):1677-83. doi: 10.1200/JCO.1998.16.5.1677. J Clin Oncol. 1998. PMID: 9586878 Clinical Trial.

8

Vitronectin binding to urokinase receptor in human breast cancer.

Carriero MV, Del Vecchio S, Franco P, Potena MI, Chiaradonna F, Botti G, Stoppelli MP, Salvatore M. Carriero MV, et al. Clin Cancer Res. 1997 Aug;3(8):1299-308. Clin Cancer Res. 1997. PMID: 9815812

9

Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence.

Chiaradonna F, Fontana L, Iavarone C, Carriero MV, Scholz G, Barone MV, Stoppelli MP. Chiaradonna F, et al. Among authors: carriero mv. EMBO J. 1999 Jun 1;18(11):3013-23. doi: 10.1093/emboj/18.11.3013. EMBO J. 1999. PMID: 10357814 Free PMC article.

10

Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer.

Carriero MV, Del Vecchio S, Capozzoli M, Franco P, Fontana L, Zannetti A, Botti G, D'Aiuto G, Salvatore M, Stoppelli MP. Carriero MV, et al. Cancer Res. 1999 Oct 15;59(20):5307-14. Cancer Res. 1999. PMID: 10537314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters